CA2158551A1 - Medicaments pour le traitement des infections par un retrovirus - Google Patents

Medicaments pour le traitement des infections par un retrovirus

Info

Publication number
CA2158551A1
CA2158551A1 CA002158551A CA2158551A CA2158551A1 CA 2158551 A1 CA2158551 A1 CA 2158551A1 CA 002158551 A CA002158551 A CA 002158551A CA 2158551 A CA2158551 A CA 2158551A CA 2158551 A1 CA2158551 A1 CA 2158551A1
Authority
CA
Canada
Prior art keywords
extracts
drug
extract
drugs
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002158551A
Other languages
English (en)
Inventor
Hans-Georg Laves
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAVES HANS GEORG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2158551A1 publication Critical patent/CA2158551A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002158551A 1993-03-17 1994-03-08 Medicaments pour le traitement des infections par un retrovirus Abandoned CA2158551A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4308443.5 1993-03-17
DE4308443A DE4308443C2 (de) 1993-03-17 1993-03-17 Arzneimittel zur Behandlung von Retrovirusinfektionen

Publications (1)

Publication Number Publication Date
CA2158551A1 true CA2158551A1 (fr) 1994-09-29

Family

ID=6483010

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002158551A Abandoned CA2158551A1 (fr) 1993-03-17 1994-03-08 Medicaments pour le traitement des infections par un retrovirus

Country Status (12)

Country Link
EP (1) EP0689446A1 (fr)
JP (1) JP2735386B2 (fr)
AU (1) AU684755B2 (fr)
BR (1) BR9405887A (fr)
CA (1) CA2158551A1 (fr)
CZ (1) CZ238795A3 (fr)
DE (1) DE4308443C2 (fr)
HU (1) HUT73382A (fr)
PL (1) PL310659A1 (fr)
RU (1) RU2104023C1 (fr)
SK (1) SK115495A3 (fr)
WO (1) WO1994021269A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2634380B1 (fr) * 1988-07-19 1990-10-12 Beljanski Mirko Regulateur biologique, actif dans diverses pathologies
DE3832056A1 (de) * 1988-09-21 1990-03-22 Scholle Helmut Dr Med Verwendung eines ginkgo-extraktes
FR2639830B1 (fr) * 1988-12-02 1991-03-22 Beljanski Mirko Composition antivirale et ses applications
DE4105570A1 (de) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle Verwendung eines bakterien- und eiweissfreien filtrats

Also Published As

Publication number Publication date
BR9405887A (pt) 1995-12-12
JP2735386B2 (ja) 1998-04-02
EP0689446A1 (fr) 1996-01-03
SK115495A3 (en) 1996-11-06
RU2104023C1 (ru) 1998-02-10
HUT73382A (en) 1996-07-29
AU6283494A (en) 1994-10-11
WO1994021269A1 (fr) 1994-09-29
DE4308443C2 (de) 1996-09-19
HU9502697D0 (en) 1995-11-28
PL310659A1 (en) 1995-12-27
AU684755B2 (en) 1998-01-08
JPH08506595A (ja) 1996-07-16
DE4308443A1 (de) 1994-09-22
CZ238795A3 (en) 1996-02-14

Similar Documents

Publication Publication Date Title
JP3571061B2 (ja) Ｂ型肝炎ウイルス（ｈｂｖ）の複製を抑制する薬学的製剤
JP2656938B2 (ja) ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物
EP0559425B1 (fr) Utilisation des protéines de la famille transferrine/lactoferrine pour stimuler le système immunitaire
JPH06234657A (ja) インターフェロンの使用を含む複合治療のための医薬
JPH0125A (ja) ｄｓＲＮＡと逆転写酵素インヒビターを含んで成るＨＩＶ感染治療のための医薬組成物
JP2005508848A (ja) コンセンサスインターフェロンのＢ型肝炎表面抗原とｅ抗原の抑制剤としての応用
JP2005508848A6 (ja) コンセンサスインターフェロンのＢ型肝炎表面抗原とｅ抗原の抑制剤としての応用
JPH0825890B2 (ja) 抗ウイルス剤
US7829124B2 (en) Use of Phyllanthus constituents for treating or preventing infections caused by hepatitis B-viruses
HU204999B (en) Process for producing pharmaceutical compositions having antiviral activity and comprising synergetic active ingredient combination
CA2158551A1 (fr) Medicaments pour le traitement des infections par un retrovirus
US6015796A (en) Method for treating AIDS
JP3247381B2 (ja) 抗コレラトキシン剤
CN106822152B (zh) 一种药物组合物及其应用
JP3002700B2 (ja) 抗エイズウイルス剤
JP3010258B2 (ja) 抗ｈｉｖ剤
US3679793A (en) Method of raising the white blood cell count
KR100370501B1 (ko) 금은화추출물을포함하는비형간염치료제
CN110536690B (zh) 用于预防或治疗丙型肝炎病毒感染疾病的药学组合物
KR100285586B1 (ko) 5-하드록시메틸-2-푸르푸랄을 함유하는 비형 간염 치료제
KR100346611B1 (ko) 세코노가노사이드를포함하는비형간염치료제
JPS63316726A (ja) 抗レトロウィルス剤
JPH0543477A (ja) ヒト免疫不全ウイルス増殖抑制剤
JPH02145517A (ja) エイズ発症防止、治療剤及び該治療用組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead